Process for controlling fungi diseases with acetyl-4-trifluoromethyl-salicylic acid



United States Patent ()filice Patented Nov. 20, 195.2

PRfiCESd FOR CCNTRGLLING FUNGH DESEASES WITH ACETYL 4 TRIFLUCROMETHYL SALI- CYLHC ACID Murray Hauptschein, Gleuside, Pa., assignor to Pennsait Chemicals Corporation, Philadelphia, Pa., a corporation of Pennsylvania No Drawing. Original application May 15, 1958, Ser. No. 735,642, new Patent No. 3,019,253, dated Jan. 30, 1962. Divided and this application Mar. 27, 1961, Ser. No. 107,610

1 Claim. (Cl. 16758) One and one-half grams of 4-trifiuoromethylsalicylic acid were mixed with 5 ml. of acetic anhydride and two drops of concentrated sulfuric acid and maintained at about 20 C. to 30 C. Reaction began at once and proceeded rapidly to completion. Acetyl-4-trifluoromethylsalicylic acid was obtained in almost quantitative yield. Upon recrystallization from a petroleum ether-ethyl ether mixture, the product, which was a mat of fine white needles, melted at 110112 C. when placed in a bath previously heated to 108 C. It was difiicult to get consistent values for the melting point of the sample when heating slowly from room temperature.

Analysis.-Calcd. for C I-I O F C, 40.40; H, 2.84. Found: C, 48.64; H, 3.00.

Acetyl-4-trifluoromethylsalicylic acid is miscible with ethanol but only very slightly soluble in water. No coloration was obtained with aqueous ferric chloride. However, on standing overnight the solution slowly developed a violet-red color due to hydrolysis of the ester. The ester was hydrolyzed intentionally with 25% sodium hydroxide at 70 C. for six hours, and after acidification the original acid, MP. l77l78 C., was isolated.

Acetyl-4-trifluoromethylsalicylic acid can also be prepared by using acetyl chloride as the acetylating agent. Also, zinc chloride or sodium acetate can be used as the catalyst in place of the sulfuric acid.

The reaction can be carried out in the temperature range from about C. to about the 100 C. A temperature in the range 20 C. to 40 C. is preferred.

The acetylating agent is preferably used in an amount sufficiently in excess of the stoichiometric quantity to serve as the reaction medium. Acetyl-4-trifluororneth ylsalicylic acid is recovered by crystallization from the reaction mass and by recrystallization from a petroleum ether-ether solvent mixture.

The amount of catalyst used in the reaction is about the same as that commonly used in the art for acetylation reactions, ranging from about 0.1% to about 10% by weight of the acetylating agent. An amount of 0.1% to about of catalyst is preferred.

Acetyl-4-trifiuorornethylsalicylic acid has the following structure:

CFa

ll OCCHa I COOH The novel compound of this invention has been found to cause analgesia in animals in much the same manner as aspirin and similar pain-relieving compounds.

The analgetic activity of acethyl-4-trifluoromethylsalicylic acid is demonstrated in the following example.

EXAMPLE 2 Acethl-4-triiiuoromethylsalicylic acaid (ATMSA) was administered to rats in oral doses of and 200 mg./kg. of body weight and the results were compared to result obtained with aspirin and codeine. The data and results are shown in Table I.

Table 1 Dose, Analgetic Drug msL/kg. Units/Test Percent Side Eficcts per os Units ATMSA 100 14/60 28. 2 No side etiects. AT MSA 200 14/60 23. 2 Do. Aspirin- 300 3/18 16. 7 Do. Codeine... 100 24/42 57 Quiet, tense.

From the above data it will be noted that acetyl-4-trifiuoromethylsalicylic acid produces analgesia in doses lower than usually seen with common aspirin, acetyl- Salicylic acid.

Acetyl-4-trifluoromethylsalicylic acid also is useful as a fungicide. Its fungicidal activity is demonstrated in the following example.

EXAMPLE 3 A 5% solution of acetyl-4-trifiuoromethylsalicylic acid in polyethylene glycol 200 (M.W.) was prepared and used in control of the growth of T. mentagrophytes. Salicylic acid was used for comparison of the relative activity with a diluent control sample. The data and results are shown in Table II, where +=growth and 0=no growth.

From the test results it will be noted that acetyl-4-trifiuoromethylsalicylic acid killed the organism within S to 15 minutes exposure time, demonstration definite antifungal activity. It is also shown to be substantially better than salicylic acid in this test.

9 4i 0 EXAMPLE 4 is to be understood that the invention is not intended to be limited by the above-noted specific embodiments. A beneficial keratolytic powder for treatment of rlng- I l i WOfm Of the feet is P p y mixing togethfif five A process of controlling fungal diseases of the epiderparts of acetyl-4-trifluoromethylsalicylic acid, two parts 5 i b l i thereto a f i id l amount f 14- menthol, eight parts of camphor, 50 parts of boric acid ifl h l li li id,

and 35 parts of starch.

The above described embodiments of the invention are References m the file of thls patent presented for the purpose of illustration. As many Wide- Hauptschein, Nodiff, Saggiomo: Am. Chem. 500.,

lv difierent embodiments of this invention can be made 10 124th Meeting, Abs. of papers, September 6l1, 1953, without departing from the spirit and scope thereof, it 28M. 

